Clinical Trial Update: A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 study evaluating LTP001 in healthy volunteers and patients with pulmonary arterial hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• LTP001

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Healthy Volunteers, Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: RECRUITING